Independent Emergence of the Plasmodium falciparum Kelch Propeller Domain Mutant Allele C580Y in Guyana

Journal of Infectious Diseases

Volumn 213, Issue 9, 2016, Pages 1472-1475

  Chenet, Stella M ^a   Akinyi Okoth, Sheila ^a,b   Huber, Curtis S ^a   Chandrabose, Javin ^d   Lucchi, Naomi W ^a   Talundzic, Eldin ^a,b   Krishnalall, Karanchand ^d   Ceron, Nicolas ^e   Musset, Lise ^g   Macedo De Oliveira, Alexandre ^a   Venkatesan, Meera ^c   Rahman, Reyaud ^f   Barnwell, John W ^a   Udhayakumar, Venkatachalam ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Atlanta Research and Education Foundation   (United States)

^c UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^d Ministry of Health Guyana   (Guyana)

^e PAN AMERICAN HEALTH ORGANIZATION   (Guyana)

^f Georgetown   (Guyana)

^g INSTITUT PASTEUR DE LA GUYANE   (French Guiana)

Author keywords

ACTartemisinin resistance; Guyana; K13; malaria; Plasmodium falciparum; South America

Indexed keywords

ARTEMISININ; CHLOROQUINE; CYSTEINE; MEFLOQUINE; MUTANT PROTEIN; PYRIMETHAMINE PLUS SULFADOXINE; TYROSINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; PROTOZOAL DNA;

ALLELE; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; DRUG EFFICACY; DRUG SCREENING; GENE; GENOTYPE; GUYANA; HUMAN; MALARIA FALCIPARUM; MICROSATELLITE MARKER; MOLECULAR GENETICS; NONHUMAN; PFCRT GENE; PFDHFR GENE; PFDHPS GENE; PFK13 GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DOMAIN; SOUTHEAST ASIA; COMBINATION DRUG THERAPY; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; MALARIA, FALCIPARUM; MOLECULAR TYPING; MUTATION; PARASITOLOGY;

ANTIMALARIALS; ARTEMISININS; DNA, PROTOZOAN; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; GUYANA; HUMANS; MALARIA, FALCIPARUM; MOLECULAR TYPING; MUTATION; PLASMODIUM FALCIPARUM;

EID: 84971657534     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv752     Document Type: Article

References (15)

1. Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361:455-67.
2. WorldHealthOrganization. Status report on artemisinin andACT resistance.Geneva: World Health Organization, 2015. http://www.who.int/malaria/publications/atoz/update-artemisinin-resistance-sep2015/en/. Accessed 4 October 2015.
3. Vreden SG, Jitan JK, Bansie RD, Adhin MR. Evidence of an increased incidence of day 3 parasitaemia in Suriname: an indicator of the emerging resistance of Plasmodium falciparum to artemether. Mem Inst Oswaldo Cruz 2013; 108:968-73.
4. Wootton JC, Feng X, Ferdig MT, et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002; 418:320-3.
5. McCollum AM, Mueller K, Villegas L, Udhayakumar V, Escalante AA. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. Antimicrob Agents Chemother 2007; 51:2085-91.
6. Akinyi Okoth S, Abdallah JF, Ceron N, et al. Variation in Plasmodium falciparum histidine-rich protein 2 (Pfhrp2) and Plasmodium falciparum histidine-rich protein 3 (Pfhrp3) gene deletions in Guyana and Suriname. PLoS One 2015; 10: e0126805.
7. Talundzic E, Chenet SM, Goldman IF, et al. Genetic analysis and species specific amplification of the artemisinin resistance-associated Kelch propeller domain in P. falciparum and P. vivax. PLoS One 2015; 10:e0136099.
8. Vinayak S, Alam MT, Mixson-Hayden T, et al. Origin and evolution of sulfadoxine resistant Plasmodium falciparum. PLoS Pathog 2010; 6:e1000830.
9. Griffing S, Syphard L, Sridaran S, et al. pfmdr1 amplification and fixation of pfcrt chloroquine resistance alleles in Plasmodium falciparum in Venezuela. Antimicrob Agents Chemother 2010; 54:1572-9.
10. Cheeseman IH, Miller BA, Nair S, et al. A major genome region underlying artemisinin resistance in malaria. Science 2012; 336:79-82.
11. Talundzic E, Okoth SA, Congpuong K, et al. Selection and spread of artemisininresistant alleles in Thailand prior to the global artemisinin resistance containment campaign. PLoS Pathog 2015; 11:e1004789.
12. Anderson TJ, Su XZ, BockarieM, Lagog M, Day KP. Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples. Parasitology 1999; 119 (pt 2):113-25.
13. Enserink M. Combating malaria. Malaria treatment: ACT two. Science 2007; 318:560-3.
14. Ariey F, Witkowski B, Amaratunga C, et al. A molecular marker of artemisininresistant Plasmodium falciparum malaria. Nature 2014; 505:50-5.
15. Sisowath C, Ferreira PE, Bustamante LY, et al. the role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Trop Med Int Health 2007; 12:736-42.